Premier Fund Managers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.43M Sell
134,706
-1,165
-0.9% -$77.6K 0.85% 56
2026
Q1
$8.41M Sell
135,871
-62,915
-32% -$4.38M 0.6% 65
2025
Q4
$13.3M Sell
198,786
-18,300
-8% -$1.18M 0.77% 47
2025
Q3
$14.4M Buy
217,086
+58,588
+37% +$4.64M 0.59% 54
2025
Q2
$13.7M Buy
+158,498
New +$12.4M 0.5% 50
2020
Q3
Sell
-45,324
Closed -$4.59M 212
2020
Q2
$4.59M Buy
+45,324
New +$4.05M 0.29% 81

Other funds holding DXCM

Premier Fund Managers's DXCM Position: Q2 2026 in Review

Premier Fund Managers reduced its DexCom (DXCM) stake by 0.86% in Q2 2026, selling an estimated $77.6K and leaving 134,706 shares worth $9.43M. The position accounts for 0.85% of the portfolio, ranked #56.

Premier Fund Managers first reported a position in DXCM in Q2 2020 and has held it in 6 quarters since. The position peaked at $14.4M in Q3 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Premier Fund Managers held 134,706 shares of DexCom worth $9.43M as of Q2 2026.
  • Premier Fund Managers sold 1,165 DexCom shares in Q2 2026, an estimated $77.6K.
  • DexCom made up 0.85% of Premier Fund Managers's portfolio in Q2 2026, its #56 holding.
  • Premier Fund Managers first reported a position in DexCom in Q2 2020 and has held it in 6 quarters since.
  • Premier Fund Managers's DexCom position peaked at $14.4M in Q3 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Premier Fund Managers's 13F filing for Q2 2026, filed 22 Jul 2026.